Two 12-week phase 3 trials and a 43-week extension will test 8 mg and 16 mg HLP003 added to antidepressants, with APPROACH enrollment now complete.
|Articles|September 16, 2008
- March31 2003
- Volume 10
- Issue 6
FREE ONLINE FILING
Author(s)Michael Sheehan
Advertisement
More than 1 in 3 federal incometax returns were filed electronicallylast year, and the IRS (www.irs.gov)expects a 25% jump in the number ofe-filings this year.To make online filingeasier, the agency has pulledtogether 17 tax software companiesthat offer free online filing services.Because most of the companiesrequire that you have a low adjustedgross income (AGI), doctors mayfind it difficult to qualify. There are 2services that have no limit on AGI,although they are limited geographically.The Web site eSmartTax.comwill file your return electronicallyfor free if you live in California,Georgia, Illinois, North Carolina, orOhio.You can also get online filingat no charge from the site Fileyourtaxes.com if you live in Arizona,Georgia, Michigan, or Wisconsin.
Articles in this issue
about 18 years ago
WAR AND WALL STREETabout 18 years ago
THE 529 FACTSabout 18 years ago
A WILL THAT WORKSabout 18 years ago
WALL STREET WOESabout 18 years ago
FINANCIAL PLANNING KEYabout 18 years ago
MIXED SIGNALSabout 18 years ago
PAPERWORK REDUCTIONabout 18 years ago
SHRINKING GIFTSabout 18 years ago
Medicare Cuts Deniedabout 18 years ago
DID YOU KNOW…Advertisement
Related to this article
This preview of EADV 2026 provides a teaser of new data and interviews being highlighted at this Vienna dermatology conference.
Phase 2b AMPLIFIED data show a 42.7% UACR drop in AMKD with modest proteinuria; AMPLITUDE interim data are due early 2027.
George Vasquez-Rios, MD, explains how the ASN's GD-C Compendium curates glomerular disease guidance for general clinicians and specialists alike.
Andrew Cutler, MD, says real-world MDD patients respond to adjunctive cariprazine like trial participants, with gains in mood and function within weeks.
Frances Lee, MD, on the stigma driving under-detection of ALD and its disproportionate rise in women and younger adults.
SOCS leaders explain SOCS Serves, a toolkit-based program connecting dermatology volunteers with students and underserved communities.
EMBARQ-CSU1 and EMBARQ-CSU2 showed sustained reductions in urticaria, with the antibody meeting all primary and key secondary endpoints at Week 12.
Advertisement
Advertisement
Trending on HCPLive
1
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
2
ProACt Data Show Early Functional Gains with Adjunctive Cariprazine In MDD
3
FDA Updates Sotatercept Label with HYPERION Data in Early PAH
4
EMBARQ-CSU: Barzolvolimab Meets Primary, Secondary Endpoints in CSU Trials
5